The evaluation of β-(1 → 3)-nonaglucoside as an anti-<i>Candida albicans</i>immune response inducer

Ema Paulovičová, Lucia Paulovičová, Ružena Pilišiová, Viera Jančinová, Dmitry V. Yashunsky, Yury E. Tsvetkov, Nikolay E. Nifantiev

Cellular Microbiology · 2016 · 13 citations · 31 references

Concepts

Abstract

Synthetically prepared bovine serum albumin (BSA) conjugate of linear β-(1 → 3)-nonaglucoside ligand (G9) has been applied as a biological response immunomodulator in vivo and ex vivo. Active immunization of Balb/c mice revealed effective induction of specific humoral responses in comparison with Candida β-D-glucan and Candida whole cells. Induced post-vaccination serum exhibited a growth-inhibition effect on the multi-azole-resistant clinical strain Candida albicans CCY 29-3-164 in experimental mucocutaneous infection ex vivo. Evaluation of immune cell proliferation and the cytotoxic potential of the G9-ligand has revealed its bioavailability and an immunostimulative effect in vaccination-sensitized Balb/c mice splenocytes and RAW 264.7 macrophages.

References

31